亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

High-Mobility Group Box 1 Preconditioning Protects Against Liver Ischemia-Reperfusion Injury

详细技术说明
None
*Abstract
High mobility group box 1 (HMGB1) is a nuclear factor released extracellularly as a late mediator of lethality in sepsis as well as following necrotic but not apoptotic death. Here we demonstrate that in contrast to the proinflammatory role of HMGB1, preconditioning with HMGB1 results in protection from inflammation and organ injury following hepatic ischemia and reperfusion (I/R). Pretreatment of mice with HMGB1 significantly decreased liver damage after I/R in association with markedly lower serum TNF and IL-6 compared to controls. The protection observed in mice pretreated with HMGB1 was associated with a higher expression of IL-1R-associated kinase-M (IRAK-M), a negative regulator of toll-like receptor (TLR)-4 signaling compared to controls. We thus explored the possibility that HMGB1 preconditioning was mediated through TLR4 activation. HMGB1 preconditioning failed to provide protection in TLR4 mutant (C3H/HeJ) mice, but successfully reduced damage in TLR4 wild-type (C3H/HeOuj) mice. Use of HMGB1 as a preconditioning agent may be a potential strategy in settings of ischemic injury to decrease organ damage.Use of HMGB1 as a preconditioning agent may be a potential strategy in settings of ischemic injury to decrease organ damage.Non Provisional and PCT Patent Applications Filed
*Principal Investigation

Name: Timothy Billiar, Chairman

Department: Med-Surgery


Name: Mitchell Fink, Professor

Department: Med-Critical Care Medicine


Name: Kevin Tracey, Head, Cnt. for Patient Oriented Rsch

Department:


Name: Allan Tsung, Graduate Medical Trainee

Department: Med-Surgery

国家/地区
美国

欲了解更多信息,请点击 这里
移动设备